with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase. Lancet. 2017 Jun 24;389(10088):2473–2481. doi: 10.1016/S0140–6736(17)31075–9. Epub 2017 May 2. PMID: 28476288.

19. MacKrill K, Gamble GD, Petrie KJ. The Effect of Television and Print News Stories on the Nocebo Responding Following a Generic Medication Switch. Clin Psychol Eur. 2020 Jun 30;2(2): e2623. doi: 10.32872/cpe.v2i2.2623. PMID: 36397827; PMCID: PMC9645488.

20. Di Blasi Z, Harkness E, Ernst E, Georgiou A, Kleijnen J. Influence of context effects on health outcomes: a systematic review. Lancet. 2001 Mar 10;357(9258):757–62. doi: 10.1016/s0140–6736(00)04169–6. PMID: 11253970.

21. “Captain Cook and the Scourge of Scurvy” BBC – History. Последний доступ 9 октября 2023 https://www.bbc.co.uk/history/british/empire_seapower/captaincook_scurvy_01.shtml

22. Streptomycin treatment of pulmonary tuberculosis: a Medical Research Council investigation. BMJ 2:769–782. Доступен https://www.jameslindlibrary.org/medical-research-council‐1948b/

23. Balint M. e doctor, the patient and the illness. London: Pitman Medical Publishing Co.; 1957

24. Of the imagination, as a cause and as a cure of disorders of the body: exemplified by fictitious tractors, and epidemical convulsions. Bath: R. Crutwell. https://www.jameslindlibrary.org/haygarth-j‐1800/

25. Nichols JTG. The misuses of drugs in modern practice. Massachusetts Medical Society, Medical Communications. 1893;16:3–46. page 28

26. https://countway.harvard.edu/news/backblog-elisha-perkins-metallic-tractors

27. Shorter E. A brief history of placebos and clinical trials in psychiatry. Can J Psychiatry. 2011 Apr;56(4):193–7. doi: 10.1177/070674371105600402. PMID: 21507275; PMCID: PMC3714297.

28. Zunhammer M, Spisák T, Wager TD, Bingel U; Placebo Imaging Consortium. Meta-analysis of neural systems underlying placebo analgesia from individual participant fMRI data. Nat Commun. 2021 Mar 2;12(1):1391. doi: 10.1038/s41467–021–21179–3. PMID: 33654105; PMCID: PMC7925520.

29. Motta LS, Gosmann NP, Costa MDA, et alPlacebo response in trials with patients with anxiety, obsessive-compulsive and stress disorders across the lifespan: a three-level meta-analysisBMJ Ment Health 2023;26: e300630.

30. Previtali D, Merli G, Di Laura Frattura G, Candrian C, Zaffagnini S, Filardo G. The Long-Lasting Effects of “Placebo Injections” in Knee Osteoarthritis: A Meta-Analysis. Cartilage. 2021 Dec;13(1_suppl):185S‐196S. doi: 10.1177/1947603520906597. Epub 2020 Mar 18. PMID: 32186401; PMCID: PMC8808779.

31. Suarez-Almazor ME, Looney C, Liu Y, Cox V, Pietz K, Marcus DM, Street RL Jr. A randomized controlled trial of acupuncture for osteoarthritis of the knee: effects of patient-provider communication. Arthritis Care Res (Hoboken). 2010 Sep;62(9):1229–36. doi: 10.1002/acr.20225. PMID: 20506122; PMCID: PMC3651275.

32. Kirchhof J, Petrakova L, Brinkhoff A, Benson S, Schmidt J, Unteroberdörster M, Wilde B, Kaptchuk TJ, Witzke O, Schedlowski M. Learned immunosuppressive placebo responses in renal transplant patients. Proc Natl Acad Sci U S A. 2018 Apr 17;115(16):4223–4227. doi: 10.1073/pnas.1720548115. Epub 2018 Apr 2. PMID: 29610294; PMCID: PMC5910853.

33. Йоханн Хари. Пункт назначения: счастье. Как путешествие длиною 40 000 миль раскрыло реальные причины депрессии и подарило надежду на полноценную жизнь. https://bombora.ru/book/45079/

34. Evers AWM, Colloca L, Blease C, Annoni M, Atlas LY, Benedetti F, et al. Implications of placebo and nocebo effects for clinical practice: expert consensus. Psychother Psychosom. 2018;87(4):204–10. https://doi.org/10.1159/000490354.

35. Hafliðadóttir, S.H., Juhl, C.B., Nielsen, S.M. et al. Placebo response and effect in randomized clinical trials: meta-research with focus on contextual effects. Trials 22, 493 (2021). https://doi.org/10.1186/s13063–021–05454–8

36. Kirsch, I., & Sapirstein, G. (1998). Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication. Prevention & Treatment, 1(2), Article 2a. https://doi.org/10.1037/1522–3736.1.1.12a

37. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008 Feb;5(2): e45. doi: 10.1371/journal.pmed.0050045. PMID: 18303940; PMCID: PMC2253608.

38. Zettler M, Basch E, Nabhan C. Surrogate End Points and Patient-Reported Outcomes for Novel Oncology Drugs Approved Between 2011 and 2017. JAMA Oncol. 2019;5(9):1358–1359. doi:10.1001/jamaoncol.2019.1760

39. Hróbjartsson A, Gøtzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med. 2001 May 24;344(21):1594–602. doi: 10.1056/NEJM200105243442106. Erratum in: N Engl J Med 2001 Jul 26;345(4):304. PMID: 11372012.

40. Тихова Галина Петровна Планируем клиническое исследование. Вопрос 2: выбор конечных точек // Регионарная анестезия и лечение острой боли. 2014. № 4. URL: https://cyberleninka.ru/article/n/planiruem-klinicheskoe-issledovanie-vopros‐2‐vybor-konechnyh-tochek (дата обращения: 22.04.2022).

ГЛАВА 8

1. Subbiah, V. The next generation of evidence-based medicine. Nat Med 29, 49–58 (2023). https://doi.org/10.1038/s41591–022–02160‐z

2. https://www.nature.com/articles/s41591–022–02160‐z/figures/1

3. https://biolight.com.ua/blog/kak-zarabotat-dengi-na-biodobavkah-pod-sobstvennoy-torgovoy-markoy

4. https://www.google.com/url?q=https://stepbystepbusiness.com/business-ideas/start-a-supplement-business/&sa=D&source=docs&ust=1697875380830281&usg=AOvVaw3BuzcQvMKfHj7pgCz3TCPl

5. https://www.rbc.ru/own_business/07/12/2018/5c07ec619a7947168ea0dc6b

6. https://foodsupplements.freyrsolutions.com/food-supplements-regulatory-services-in-usa

7. Витамины и БАДы. Фармацевт об их пользе и вреде. Автор: Кристин Гиттер. Бомбора 2020

8. Федеральный закон от 13.03.2006 № 38-ФЗ (ред. от 01.05.2019) «О рекламе»;

9. Li J, Somers VK, Xu H, Lopez-Jimenez F, Covassin N. Trends in Use of Melatonin Supplements Among US Adults, 1999–2018. JAMA. 2022;327(5):483–485. doi:10.1001/jama.2021.23652

10. Brasure M, MacDonald R, Fuchs E, Olson CM, Carlyle M, Diem S, Koffel E, Khawaja IS, Ouellette J, Butler M, Kane RL, Wilt TJ. Management of Insomnia Disorder. Comparative Effectiveness Review No. 159. (Prepared by the Minnesota Evidence-based Practice Center under Contract No. 290–2012–00016-I). AHRQ Publication No.15(16)-EHC027– EF. Rockville, MD: Agency for Healthcare Research and Quality. December 2015. www.effectivehealthcare.ahrq.gov/reports/final.cfm.

11. Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL (February 2017). “Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline”. J Clin Sleep Med. 13 (2): 307–349. doi:10.5664/jcsm.6470. PMC 5263087. PMID 27998379.

12. “Slenyto EPAR”. European Medicines Agency (EMA). Retrieved 31 May 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

13. Abdelgadir IS, Gordon MA, Akobeng AK (December 2018). “Melatonin for the management of sleep problems in children with neurodevelopmental disorders: a systematic review and meta-analysis” (PDF). Archives of Disease in Childhood. 103 (12): 1155–1162. doi:10.1136/archdischild‐2017–314181. PMID 29720494. S2CID 19107081.

14. Circadin: EPAR – Product Information ANNEX I – SUMMARY OF PRODUCT CHARACTERISTICS (Report). European Medicines Agency (EMA). 2 February 2021. EMEA/H/C/000695 – IA/0066. As PDF. Archived 31 October 2022 at the Wayback Machine Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

15. Matheson E, Hainer BL (July 2017). “Insomnia: Pharmacologic Therapy”. American Family Physician. 96 (1): 29–35. PMID 28671376.

16. Braam W, Smits MG, Didden R, Korzilius H, Van Geijlswijk IM, Curfs LM (May 2009). “Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis”. Developmental Medicine and Child Neurology (Meta-analysis). 51 (5): 340–9. doi:10.1111/j.1469–8749.2008.03244.x. PMID 19379289. S2CID 35553148.

17. Rossignol DA, Frye RE (September 2011). “Melatonin in autism spectrum disorders: a systematic review and meta-analysis”. Developmental Medicine and Child Neurology (Meta-analysis). 53 (9):